NCT01968616Unknown不适用
Predictive Factors of 2-year Visual Outcome in Retinal Vein Occlusion Following Intravitreal Ranibizumab Treatment
Kyoto University, Graduate School of Medicine1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2013年9月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Mean foveal thickness measured by SD-OCT
研究概览
简要总结
In retinal vein occlusion, predictive factors for visual outcome after ranibizumab treatment have not been evaluated comprehensively. Therefore, we have planned to analyze predictors for visual outcome from a viewpoint of electrophysiology and biomarkers besides morphological features by SD-OCT.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Signed informed consent form
- •Male or female of aged 18 years or older
- •Macula edema secondary to BRVO/CRVO
- •Decrease of VA due to macular edema
排除标准
- •Prior episode of RVO
- •Previous treatment with anti-VEGF drugs or corticosteroid or grid laser photocoagulation (study eye)
- •Ocular disorders in the study eye that may confound interpretation of study results
- •History of vitrectomy surgery, submacular surgery, or other surgical intervention for RVO
- •The pregnant or lactating woman
研究组 & 干预措施
Intravitreal Lucentis 0.5mg
Other
One arm
干预措施: Ranibizumab, 0.5mg, Intravitreal (Drug)
结局指标
主要结局
Mean foveal thickness measured by SD-OCT
时间窗: 2 years
次要结局
未报告次要终点
研究者
Nagahisa Yoshimura
Department of Ophthalmology & Visual Sciences
Kyoto University, Graduate School of Medicine
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Long Term Outcome of Intravitreal Ranibizumab for ROPRetinopathy of PrematurityNCT04537065Ameera Gamal Abdelhameed140
已完成
不适用
ong-term Outcome of Intravitreal Ranibizumab Treatment, Compared with Photodynamic Therapy, in Patients with Polypoidal Choroidal Vasculopathypolypoidal choroidal vasculopathyJPRN-UMIN000008630Yokohama City University Medical Center80
Unknown
4 期
Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein OcclusionTreatmentPhotocoagulation Burn to RetinaRanibizumabRetinal Vein OcclusionNCT04062370Sun Yat-sen University100
Unknown
不适用
Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVOCentral Retinal Vein OcclusionNCT02091505Mie University30
进行中（未招募）
不适用
Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study - RABAMESEUCTR2006-006131-53-DESociety (institute) for clinical research